1
|
Suárez I, Rauschning D, Schüller C, Hagemeier A, Stecher M, Lehmann C, Schommers P, Schlabe S, Vehreschild JJ, Koll C, Schwarze-Zander C, Wasmuth JC, Klingmüller A, Rockstroh JK, Fätkenheuer G, Boesecke C, Rybniker J. Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne-Bonn region: a retrospective cohort study. Infection 2024:10.1007/s15010-024-02215-y. [PMID: 38492196 DOI: 10.1007/s15010-024-02215-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2023] [Accepted: 02/13/2024] [Indexed: 03/18/2024]
Abstract
PURPOSE The risk of developing active tuberculosis (TB) is considerably increased in people living with HIV/AIDS (PLWH). However, incidence of HIV/TB coinfection is difficult to assess as surveillance data are lacking in many countries. Here, we aimed to perform a quantitative analysis of HIV/TB coinfections within the Cologne/Bonn HIV cohort and to determine risk factors for active TB. METHODS We systematically evaluated data of patients with HIV/TB coinfection between 2006 and 2017. In this retrospective analysis, we compared HIV/TB-coinfected patients with a cohort of HIV-positive patients. The incidence density rate (IDR) was calculated for active TB cases at different time points. RESULTS During 2006-2017, 60 out of 4673 PLWH were diagnosed with active TB. Overall IDR was 0.181 cases/100 patient-years and ranged from 0.266 in 2006-2009 to 0.133 in 2014-2017. Patients originating from Sub-Saharan Africa had a significantly (p < 0.001) higher IDR (0.694/100 patient-years of observation, 95% CI [0.435-1.050]) in comparison to patients of German origin (0.053/100 patient-years of observation, 95% CI [0.028-0.091]). In terms of TB-free survival, individuals originating from countries with a TB incidence higher than 10/100,000 exhibited a markedly reduced TB-free survival compared to those originating from regions with lower incidence (p < 0.001). In 22 patients, TB and HIV infection were diagnosed simultaneously. CONCLUSION Overall, we observed a decline in the incidence density rate (IDR) of HIV/TB coinfections between 2006 and 2017. Patients originating from regions with high incidence bear a higher risk of falling ill with active TB. For PLWH born in Germany, the observed risk of active TB appears to be lower compared to other groups within the cohort. These findings should be considered when developing TB containment and screening strategies for PLWH in low-incidence countries.
Collapse
Affiliation(s)
- Isabelle Suárez
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
| | - Dominic Rauschning
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
- Department IB of Internal Medicine, Bundeswehrzentralkrankenhaus Koblenz, Koblenz, Germany
| | - Cora Schüller
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
| | - Anna Hagemeier
- Medical Faculty and University Hospital Cologne, Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany
| | - Melanie Stecher
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
| | - Clara Lehmann
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
- Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
| | - Philipp Schommers
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
- Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
| | - Stefan Schlabe
- Department of Medicine I, University Hospital Bonn, Bonn, Germany
| | - Jörg-Janne Vehreschild
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
- Medical Department 2 (Hematology/Oncology and Infectious Diseases), Center for Internal Medicine, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany
| | - Carolin Koll
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
| | - Carolynne Schwarze-Zander
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
- Department of Medicine I, University Hospital Bonn, Bonn, Germany
- Gemeinschaftspraxis am Kaiserplatz, Bonn, Germany
| | - Jan-Christian Wasmuth
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
- Department of Medicine I, University Hospital Bonn, Bonn, Germany
| | - Angela Klingmüller
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
| | - Jürgen Kurt Rockstroh
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
- Department of Medicine I, University Hospital Bonn, Bonn, Germany
| | - Gerd Fätkenheuer
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
| | - Christoph Boesecke
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany
- Department of Medicine I, University Hospital Bonn, Bonn, Germany
| | - Jan Rybniker
- Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany.
- Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
| |
Collapse
|
2
|
Matovelle P, Oliván-Blázquez B, Domínguez-García M, Casado-Vicente V, Pascual de la Pisa B, Magallón-Botaya R. Health Outcomes for Older Patients with Chronic Diseases During the First Pandemic Year. Clin Interv Aging 2024; 19:385-397. [PMID: 38464598 PMCID: PMC10924748 DOI: 10.2147/cia.s444716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2023] [Accepted: 02/06/2024] [Indexed: 03/12/2024] Open
Abstract
Background Worldwide, chronic diseases are prevalent among the older adults, significantly affecting their health and healthcare system. The COVID-19 pandemic exacerbated these challenges, disrupting healthcare services. Our study assesses the impact on older individuals with chronic diseases who were not infected with COVID-19, analyzing comorbidities, medication use, mortality rates, and resource utilization using real data from Aragon, Spain. Methods A retrospective observational study, conducted in Aragon, Spain, focused on individuals aged 75 and older with at least one chronic disease, who were not infected of COVID-19. The research used actual data collected during three distinct periods: the first covered the six months prior to the pandemic, the second the six months after the lockdown, and the third the period between six and twelve months. Key variables included socio-demographics, comorbidities, clinical parameters, medication use, and health services utilization. Results We included 128.130 older adults. Mean age was 82.88 years, with 60.3% being women. The most common chronic diseases were hypertension (73.2%), dyslipidemia (52.5%), and dorsopathies (31.5%). More than 90% had more than 2 conditions. A notable decline in new chronic disease diagnoses was observed, particularly pronounced in the six to twelve months period after lockdown. Although statistically significant differences were observed in all clinical variables analyzed, they were considered clinically irrelevant. Furthermore, a decrease in healthcare services utilization and medication prescriptions was reported. Conclusion Our study highlights a decrease in new chronic disease diagnoses, ongoing reductions in healthcare utilization, and medication prescriptions for older adults with pre-existing chronic conditions, unaffected by COVID-19.
Collapse
Affiliation(s)
- Priscila Matovelle
- Department of Geriatrics, San Juan de Dios Hospital, Zaragoza, Spain
- Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, Zaragoza, Spain
| | - Bárbara Oliván-Blázquez
- Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain
- Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), RD21/0016/0005, Zaragoza, Spain
- Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain
| | - Marta Domínguez-García
- Primary Care Research Unit (GAIAP), Aragon Health Research Institute (IISA), Zaragoza, Spain
- Aragonese Healthcare Service, Zaragoza, Spain
| | - Verónica Casado-Vicente
- Parquesol Primary Care Center, Valladolid, Spain
- Department of Medicine, University of Valladolid, Valladolid, Spain
| | - Beatriz Pascual de la Pisa
- Santa María de Gracia Primary Care, Seville, Spain
- Department of Medicine, University of Seville, Seville, Spain
- Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), RD21/0016/0015, Zaragoza, Spain
| | - Rosa Magallón-Botaya
- Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, Zaragoza, Spain
- Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain
- Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), RD21/0016/0005, Zaragoza, Spain
- Parquesol Primary Care Center, Valladolid, Spain
| |
Collapse
|
3
|
Guisado-Clavero M, Astier-Peña MP, Gómez-Bravo R, Ares-Blanco S. Open data for monitoring COVID-19 in Spain: Descriptive study. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (ENGLISH ED.) 2024; 42:80-87. [PMID: 37088686 PMCID: PMC10073586 DOI: 10.1016/j.eimce.2023.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/03/2022] [Revised: 09/28/2022] [Accepted: 10/03/2022] [Indexed: 04/09/2023]
Abstract
BACKGROUND The indicators of the pandemic have been based on the total number of diagnosed cases of COVID-19, the number of people hospitalized or in intensive care units, and deaths from the infection. The aim of this study is to describe the available data on diagnostic tests, health service used for the diagnosis of COVID-19, case detection and monitoring. METHOD Descriptive study with review of official data available on the websites of the Spanish health councils corresponding to 17 Autonomous Communities, 2 Autonomous cities and the Ministry of Health. The variables collected refer to contact tracing, technics for diagnosis, use of health services and follow-up. RESULTS All regions of Spain show data on diagnosed cases of COVID-19 and deaths. Hospitalized cases and intensive care admissions are shown in all regions except the Balearic Islands. Diagnostic tests for COVID-19 have been registered in all regions except Madrid region and Extremadura, with scarcely information on what type of test has been performed (present in 7 CCAA), requesting service and study of contacts. CONCLUSIONS The information available on the official websites of the Health Departments of the different regions of Spain are heterogeneous. Data from the use of health service or workload in Primary Care, Emergency department or Out of hours services are almost non-existent.
Collapse
Affiliation(s)
- Marina Guisado-Clavero
- Unidad Docente Multiprofesional de Atención Familiar y Comunitaria del área norte de la Comunidad de Madrid, Madrid, Spain
| | - María Pilar Astier-Peña
- Centro de Salud Univérsitas, Servicio Aragonés de Salud, Zaragoza, Spain; GdT de Seguridad del paciente de semFYC y del GdT de Calidad y Seguridad de WONCA, Zaragoza, Spain
| | - Raquel Gómez-Bravo
- Research Group Self-Regulation and Health, Institute for Health and Behaviour, Department of Behavioural and CognitiveSciences, Faculty of Humanities, Education, and Social Sciences, Universidad de Luxemburgo, Luxembourg, Luxembourg
| | - Sara Ares-Blanco
- Centro de Salud Federica Montseny, Gerencia Asistencial de Atención Primaria, Servicio Madrileño de Salud, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
| |
Collapse
|
4
|
Moreno Caballero B, Castell Alcalá MV, Gutiérrez Misis A. [Cardiovascular prevention in primary care in crisis situations: multicenter comparative study before, during and after the SARS-COVID-19 pandemic]. Aten Primaria 2024; 56:102778. [PMID: 37806071 PMCID: PMC10568233 DOI: 10.1016/j.aprim.2023.102778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2023] [Revised: 09/05/2023] [Accepted: 09/07/2023] [Indexed: 10/10/2023] Open
Abstract
OBJECTIVE To assess whether the appearance of a crisis situation such as the one caused by the SARS-COV-2 pandemic, together with the organizational changes adopted in Primary Care, have influenced the implementation of cardiovascular preventive activities in patients aged 40 to 74 years. DESIGN Retrospective multicenter descriptive study for three years (2019-2022) in Primary Care. SETTING 35 health centers of the Primary Care of the Northern Assistance Directorate of Madrid. PARTICIPANTS 1008 patients of both sexes between 40 and 74 years with diagnosed of hypertension, Diabetes Mellitus and/or dyslipidemia. METHOD The variables analyzed from the computerized clinical history were lifestyle activities (consumption of tobacco, alcohol, consumption of Mediterranean diet and exercise) considering 3 of the 4 parameters optimal; examination data (blood pressure record) and analytical record (glycemia, hbA1c, total cholesterol, HDL, LDL)considering 4 of the 5 parameters optimal. Differences are analyzed between based pre-pandemic (03/15/2019-03/14/2020), pandemic (03/15/2020-03/14/2021), and transition (03/15/2022-03/14/2022). STATISTICAL ANALYSIS MC Nemar's test to compare the main variables between the study periods. RESULTS Data from 1008 patients are collected. The registration of preventive activities on lifestyle was 180 patients (17.9%) (IC95%: 0,155-0,204) in pre-pandemic, 29 patients (2.9%) (IC 95%: 0,019-0,041) in pandemic and 55 patients (5.5%) (IC 95%: 0,041-0,070) in the transition stage (p < 0.05). Exploration was registered in 393 patients (39%) (IC95%: 0,360-0,421) in the pre-pandemic, 133 patients 13,2% (IC 95%: 0,112-0,154) in the pandemic, and 218 patients (21,6%) (IC 95%: 0,191-0,243) in the transition (p < 0.05). The analytical record was 33 patients (3.3%) (IC955: 0,023-0,046), 10 patients (1%) (IC95%: 0,005-0,018) and 23 patients (2.3%) (IC95%: 0,015-0,034) respectively in each phase with one (P < 0.05). CONCLUSIONS Activities on lifestyle, physical examination, and laboratory test as part of the cardiovascular prevention strategy are scarce in the prepandemic period and decrease drastically during the pandemic, at the first level of care.
Collapse
Affiliation(s)
- Bárbara Moreno Caballero
- Centro de salud Guayaba. Dirección Asistencial Centro. Servicio Madrileño de Salud, Madrid, España.
| | - M Victoria Castell Alcalá
- Centro de salud Dr. Castroviejo. Dirección Asistencial Norte. Servicio Madrileño de Salud, Madrid, España; Instituto de Investigación Hospital Universitario La Paz. (IdiPAZ), Madrid, España; Departamento de Medicina. Unidad Clínica Departamental de Medicina de Familia. Facultad de Medicina. Universidad Autónoma de Madrid, Madrid, España
| | - Alicia Gutiérrez Misis
- Instituto de Investigación Hospital Universitario La Paz. (IdiPAZ), Madrid, España; Departamento de Medicina. Unidad Clínica Departamental de Medicina de Familia. Facultad de Medicina. Universidad Autónoma de Madrid, Madrid, España
| |
Collapse
|
5
|
Mahuela L, Oliván-Blázquez B, Lear-Claveras A, Méndez-López F, Samper-Pardo M, León-Herrera S, Magallón-Botaya R, Sánchez-Calavera MA. Use of health services and medication use, new comorbidities, and mortality in patients with chronic diseases who did not contract COVID-19 during the first year of the pandemic: a retrospective study and comparison by sex. BMC Health Serv Res 2023; 23:1364. [PMID: 38057878 PMCID: PMC10698932 DOI: 10.1186/s12913-023-10158-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 10/16/2023] [Indexed: 12/08/2023] Open
Abstract
BACKGROUND The restrictions introduced to stop the spread of the COVID-19 virus have also had a direct impact on people with chronic diseases and especially on diseases to which lifestyles are relevant in their control and management, such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD), etc. The purpose of this paper is to conduct a longitudinal analysis of new comorbidities, mortality, medication use, and the use of health resources in patients with chronic diseases who did not contract COVID-19, comparing the six months before the strict lockdown to the 12 months following the end of the strict lockdown. METHOD An observational real world data pre-post study of 668,974 people was undertaken. The patients studied were over 16 years of age, had been receiving care from the Aragon Health Service (Northeastern Spain), were diagnosed with one or more chronic diseases, and had not contracted COVID-19. Sociodemographic, comorbidity, pharmacological and health resource use variables were collected during the six months before the onset of the lockdown and during the six and 12 months following the end of the lockdown. The comparisons by sex were carried out using a Student T-test or chi-squared test to analyse differences. RESULTS Dyslipidaemia (42.1%) followed by hypertension (35.1%) and anxiety and depression (34.6%) were the most prevalent chronic diseases among the study population. 78.% of patients had between one and four chronic illnesses. There was a decrease in new diagnoses of other chronic comorbidities in this population and a decrease in medications prescribed and the use of health services. Although women received more diagnoses of chronic diseases, the number of medications dispensed was lower, but the use of health services was higher. These figures were maintained throughout the pandemic. CONCLUSION Our results suggest an underdiagnosis of new chronic comorbidities and a decrease in mortality rates from causes unrelated to COVID-19 due to the closure of health centres in Aragón (Spain) during the lockdown. This trend was exacerbated in women. The underdiagnosis of new chronic comorbidities during confinement can cause the disease to worsen, with the consequent increase in symptoms and the worsening of chronic pathologies in patients with a severe evolution.
Collapse
Affiliation(s)
- Liliana Mahuela
- Institute for Health Research Aragon (IISAragon), Zaragoza, Spain
| | - Bárbara Oliván-Blázquez
- Institute for Health Research Aragon (IISAragon), Zaragoza, Spain
- Aragones Group of Research in Primary Health Care (GAIAP), Zaragoza, Spain
- Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain
| | - Ana Lear-Claveras
- Aragones Group of Research in Primary Health Care (GAIAP), Zaragoza, Spain
| | - Fátima Méndez-López
- Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
- Aragones Group of Research in Primary Health Care (GAIAP), Zaragoza, Spain.
- Department of Medicine, University of Zaragoza, Zaragoza, Spain.
| | | | - Sandra León-Herrera
- Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain
| | - Rosa Magallón-Botaya
- Institute for Health Research Aragon (IISAragon), Zaragoza, Spain
- Aragones Group of Research in Primary Health Care (GAIAP), Zaragoza, Spain
- Department of Medicine, University of Zaragoza, Zaragoza, Spain
| | - María Antonia Sánchez-Calavera
- Aragones Group of Research in Primary Health Care (GAIAP), Zaragoza, Spain
- Department of Medicine, University of Zaragoza, Zaragoza, Spain
| |
Collapse
|
6
|
Irigoyen-Mansilla VM, Gil-Prieto R, Gea-Izquierdo E, Barrio–Fernández JL, Hernández-Barrera V, Gil-de-Miguel A. Hospitalization burden related to herpes zoster infection during the COVID-19 pandemic in Spain (2020-2021). Hum Vaccin Immunother 2023; 19:2256047. [PMID: 37799065 PMCID: PMC10561580 DOI: 10.1080/21645515.2023.2256047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Accepted: 09/03/2023] [Indexed: 10/07/2023] Open
Abstract
Varicella-Zoster Virus (VZV) belongs to the family Herpesviridae. Herpes zoster (HZ) is caused by reactivation of latent VZV. It is associated with risk factors such as immunosenescence, immunosuppressive pathologies and pharmacological treatments. Patients with these risk factors are more likely to be hospitalized. Increases in HZ hospitalizations have been reported in many countries in recent years. The objective of this study is to estimate hospitalization rates, mortality rates and costs due to HZ during the worst years of the COVID-19 pandemic in Spain (2020-2021). This is a descriptive study based on an analysis of information from the Minimum Basic Dataset and coded according to the Spanish version of the 10th International Classification of Diseases (ICD-10-CM). Hospitalization, mortality and case-fatality rates, and median length of hospitalization were calculated.. The hospitalization rate was 14.4 cases per 100,000 inhabitants, and the mortality rate was 1.3 cases per 100,000 inhabitants. Both increased considerably with age. In this time period, 92.3% of the registered cases were people over 50 years of age. Nevertheless, during the COVID-19 pandemic period, hospitalization rate decreased and the mortality rate increased from previous years. HZ hospitalization and mortality rates are relevant issues in the public health of older people. It is highly recommended to evaluate new vaccination strategies against VZV to include the HZ vaccine for health care for elderly people, as well as to reduce the disease burden and associated risk factors. The estimation of HZ disease hospitalization costs were €100,433,904.
Collapse
Affiliation(s)
- Victor-Manuel Irigoyen-Mansilla
- Preventive Medicine Unit, Infanta Sofia University Hospital, San Sebastián de los Reyes, Spain
- Department of Medical Specialities and Public Health. Area of Preventive Medicine & Public Health, Rey Juan Carlos University, Madrid, Spain
| | - Ruth Gil-Prieto
- Department of Medical Specialities and Public Health. Area of Preventive Medicine & Public Health, Rey Juan Carlos University, Madrid, Spain
- Chair of Evaluation of Health Results, Rey Juan Carlos University, Madrid, Spain
| | - Enrique Gea-Izquierdo
- Department of Medical Specialities and Public Health. Area of Preventive Medicine & Public Health, Rey Juan Carlos University, Madrid, Spain
| | - José Luis Barrio–Fernández
- Department of Medical Specialities and Public Health. Area of Preventive Medicine & Public Health, Rey Juan Carlos University, Madrid, Spain
| | - Valentín Hernández-Barrera
- Department of Medical Specialities and Public Health. Area of Preventive Medicine & Public Health, Rey Juan Carlos University, Madrid, Spain
| | - Angel Gil-de-Miguel
- Department of Medical Specialities and Public Health. Area of Preventive Medicine & Public Health, Rey Juan Carlos University, Madrid, Spain
- Chair of Evaluation of Health Results, Rey Juan Carlos University, Madrid, Spain
| |
Collapse
|
7
|
Samper-Pardo M, Formento-Marín N, Oliván-Blázquez B, León-Herrera S, Benedé-Azagra B. Use of community resources as health assets for rehabilitation of people with Long COVID in northeastern Spain two years after the outbreak of the COVID-19 pandemic: qualitative study. Arch Public Health 2023; 81:125. [PMID: 37415256 DOI: 10.1186/s13690-023-01139-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Accepted: 06/22/2023] [Indexed: 07/08/2023] Open
Abstract
INTRODUCTION The epidemiology of Post COVID Condition is not yet known. There are different treatment options, but they are not recommended or suitable for all those affected. For this reason and due to the lack of health treatment, many of these patients have tried to carry out their own rehabilitation through the use of community resources. OBJECTIVE The objective of this study is to deepen into the understanding about the use of community resources as assets for health and rehabilitation by people with Long COVID and their utility. METHODOLOGY A qualitative design was carried out with the participation of 35 Long COVID patients, of which 17 subjects were interviewed individually and 18 of them were part of two focus groups. The participating patients were recruited in November and December 2021 from the Primary Health Care centers and through the Association of Long COVID patients of Aragon. The research topics were the use of community resources, before and after their infection by COVID-19, rehabilitation through their use, as well as barriers and strengths for their employment. All analyses were performed iteratively using NVivo software. RESULTS Long COVID patients who have used community resources for rehabilitation have seen an improvement in their physical and mental health. Most of them, specifically those affected, have used green spaces, public facilities, physical or cultural activities and associations. The main barriers identified have been the symptoms themselves and the fear of reinfection, with the main advantage of these activities being the perceived health benefits. CONCLUSION The use of community resources seems to be beneficial in the recovery process of Long COVID patients, so it is necessary to continue delving into this topic and promote the formal use of the Recommendation of Health Assets from Primary healthcare.
Collapse
Affiliation(s)
- Mario Samper-Pardo
- Institute for Health Research Aragón (IIS Aragón), C. de San Juan Bosco, 13, Zaragoza, 50009, Spain
| | - Natalia Formento-Marín
- Institute for Health Research Aragón (IIS Aragón), C. de San Juan Bosco, 13, Zaragoza, 50009, Spain
| | - Bárbara Oliván-Blázquez
- Institute for Health Research Aragón (IIS Aragón), C. de San Juan Bosco, 13, Zaragoza, 50009, Spain.
- Department of Psychology and Sociology, University of Zaragoza, Calle de Violante de Hungría, 23, Zaragoza, 50009, Spain.
- Research Network on Chronicity, Primary Care and Health Promotion (RD21/0016/0005), Carlos III Health Institute, Avda. de Monforte de Lemos, 5, Madrid, 28029, Spain.
| | - Sandra León-Herrera
- Institute for Health Research Aragón (IIS Aragón), C. de San Juan Bosco, 13, Zaragoza, 50009, Spain
| | - Belén Benedé-Azagra
- Institute for Health Research Aragón (IIS Aragón), C. de San Juan Bosco, 13, Zaragoza, 50009, Spain
- Research Network on Chronicity, Primary Care and Health Promotion (RD21/0016/0005), Carlos III Health Institute, Avda. de Monforte de Lemos, 5, Madrid, 28029, Spain
| |
Collapse
|
8
|
Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, Bugarín-González R, González-Barcala FJ, Herdeiro MT, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study. J Med Virol 2023; 95:e28971. [PMID: 37486310 DOI: 10.1002/jmv.28971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 06/09/2023] [Accepted: 07/05/2023] [Indexed: 07/25/2023]
Abstract
Evidence of the effect of statins on patients with coronavirus disease (2019) COVID-19 is inconsistent. The aim of this study was to evaluate the association between chronic use of statins-both overall and by active ingredient-and severe outcomes of COVID-19 (risk of hospitalization and mortality), progression to severe outcomes, and susceptibility to the virus. We conducted a population-based case-control study with data from electronic records to assess the risk of (1) hospitalization: cases were patients admitted due to COVID-19 and controls were subjects without COVID-19; (2) mortality: cases were hospitalized patients who died due to COVID-19 and controls were subjects without COVID-19; (3) progression: cases were hospitalized COVID-19 subjects and controls were nonhospitalized COVID-19 patients; and (4) susceptibility: cases were patients with COVID-19 (both hospitalized and nonhospitalized) and controls were subjects without COVID-19. We collected data on 2821 hospitalized cases, 26 996 nonhospitalized cases, and 52 318 controls. Chronic use of atorvastatin was associated with a decreased risk of hospitalization (adjusted odds ratios [aOR] = 0.83; 95% confidence interval [CI]: 0.74-0.92) and mortality (aOR = 0.70; 95% CI: 0.53-0.93), attributable in part to a lower risk of susceptibility to the virus (aOR = 0.91; 95% CI: 0.86-0.96). Simvastatin was associated with a reduced risk of mortality (aOR = 0.59; 95% CI: 0.40-0.87). The wide degree of heterogeneity observed in the estimated odds ratios (ORs) of the different statins suggests that there is no class effect. The results of this real-world study suggest that chronic use of atorvastatin (and to a lesser degree, of simvastatin) is associated with a decrease in risk of severe COVID-19 outcomes.
Collapse
Affiliation(s)
- Irene Visos-Varela
- Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
| | - Maruxa Zapata-Cachafeiro
- Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
- Institute of Health Research of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
- Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología y Salud Pública-CIBERESP), Santiago de Compostela, Spain
| | - Samuel Pintos-Rodríguez
- Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
| | - Rosendo Bugarín-González
- Monforte de Lemos Health Center, Health Area of Lugo, A Mariña and Monforte de Lemos, SERGAS, Monforte de Lemos, Lugo, Spain
| | - Francisco Javier González-Barcala
- Spanish Biomedical Research Networking Centre-CIBERES, Santiago de Compostela, Spain
- Pneumoloxy Department, Santiago de Compostela University Hospital Complex, Santiago de Compostela, Spain
| | - Maria T Herdeiro
- Department of Medical Sciences, iBiMED-Institute of Biomedicine, University of Aveiro, Aveiro, Portugal
| | - María Piñeiro-Lamas
- Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología y Salud Pública-CIBERESP), Santiago de Compostela, Spain
| | - Adolfo Figueiras
- Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
- Institute of Health Research of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
- Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología y Salud Pública-CIBERESP), Santiago de Compostela, Spain
| | - Ángel Salgado-Barreira
- Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
- Institute of Health Research of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
- Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología y Salud Pública-CIBERESP), Santiago de Compostela, Spain
| |
Collapse
|
9
|
Garcia-Olive I, Lopez Seguí F, Hernandez Guillamet G, Vidal-Alaball J, Abad J, Rosell A. Impact of the COVID-19 pandemic on diagnosis of respiratory diseases in the Northern Metropolitan Area in Barcelona (Spain). MEDICINA CLINICA (ENGLISH ED.) 2023; 160:392-396. [PMID: 37197392 PMCID: PMC10170319 DOI: 10.1016/j.medcle.2022.11.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Accepted: 11/11/2022] [Indexed: 05/19/2023]
Abstract
Objective The COVID-19 pandemic has had a great effect on the management of chronic diseases, by limiting the access to primary care and to diagnostic procedures, causing a decline in the incidence of most diseases. Our aim was to analyze the impact of the pandemic on primary care new diagnoses of respiratory diseases. Methods Observational retrospective study performed to describe the effect of COVID-19 pandemic on the incidence of respiratory diseases according to primary care codification. Incidence rate ratio between pre-pandemic and pandemic period was calculated. Results We found a decrease in the incidence of respiratory conditions (IRR 0.65) during the pandemic period. When we compared the different groups of diseases according to ICD-10, we found a significant decrease in the number of new cases during the pandemic period, except in the case of pulmonary tuberculosis, abscesses or necrosis of the lungs and other respiratory complications (J95). Instead, we found increases in flu and pneumonia (IRR 2.17) and respiratory interstitial diseases (IRR 1.41). Conclusion There has been a decrease in new diagnosis of most respiratory diseases during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Ignasi Garcia-Olive
- Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain
- Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Francesc Lopez Seguí
- Directorate for Innovation and Interdisciplinary Cooperation, North Metropolitan Territorial Authority, Catalan Institute of Health, Badalona, Barcelona, Spain
- Center for Research in Economy and Health, Pompeu Fabra University, Barcelona, Spain
| | - Guillem Hernandez Guillamet
- Directorate for Innovation and Interdisciplinary Cooperation, North Metropolitan Territorial Authority, Catalan Institute of Health, Badalona, Barcelona, Spain
- Center for Research in Economy and Health, Pompeu Fabra University, Barcelona, Spain
| | - Josep Vidal-Alaball
- Health Promotion in Rural Areas Research Group, Gerencia Territorial de la Catalunya Central, Institut Català de la Salut, Sant Fruitós de Bages, Barcelona, Spain
- Unitat de Suport a la Recerca de la Catalunya Central, Fundacio Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, Sant Fruitós de Bages, Barcelona, Spain
- Faculty of Medicine, University of Vic - Central University of Catalonia, Vic, Barcelona, Spain
| | - Jorge Abad
- Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain
- Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Antoni Rosell
- Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain
- Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| |
Collapse
|
10
|
Fontán-Vela M, Gullón P, Bilal U, Franco M. Social and ideological determinants of COVID-19 vaccination status in Spain. Public Health 2023; 219:139-145. [PMID: 37178560 PMCID: PMC10080268 DOI: 10.1016/j.puhe.2023.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Revised: 03/27/2023] [Accepted: 04/02/2023] [Indexed: 05/15/2023]
Abstract
OBJECTIVES This study analysed the association between social and ideological determinants with COVID-19 vaccine accessibility and hesitancy in the Spanish adult population. STUDY DESIGN This was a repeated cross-sectional study. METHODS The data analysed are based on monthly surveys conducted by the Centre for Sociological Research between May 2021 and February 2022. Individuals were classified according to their COVID-19 vaccination status into (1) vaccinated (reference group); (2) willing to vaccinate but not vaccinated, proxy of lack of vaccine accessibility; and (3) hesitant, proxy of vaccine hesitancy. Independent variables included social (educational attainment, gender) and ideological determinants (voting in the last elections, importance attached to the health vs the economic impact of the pandemic, and political self-placement). We estimated odds ratio (OR) and 95% confidence interval (CI) conducting one age-adjusted multinomial logistic regression model for each determinant and then stratified them by gender. RESULTS Both social and ideological determinants had a weak association with the lack of vaccine accessibility. Individuals with medium educational attainment had higher odds of vaccine hesitancy (OR = 1.44, CI 1.08-1.93) compared with those with high educational attainment. People self-identified as conservative (OR = 2.90; CI 2.02-4.15) and those who prioritised the economic impact (OR = 3.80; CI 2.62-5.49) and voted for parties opposed to the Government (OR = 2.00; CI 1.54-2.60) showed higher vaccine hesitancy. The stratified analysis showed a similar pattern for both men and women. CONCLUSIONS Considering the determinants of vaccine uptake and hesitancy could help to design strategies that increase immunisation at the population level and minimise health inequities.
Collapse
Affiliation(s)
- M Fontán-Vela
- Universidad de Alcalá, Facultad de Medicina y Ciencias de La Salud, Departamento de Cirugía, Ciencias Médicas y Sociales, Grupo de Investigación en Epidemiología y Salud Pública, Alcalá de Henares, Madrid, Spain; Instituto de Lengua, Literatura y Antropología, Centro Superior de Investigaciones Sociológicas, Ministerio de Ciencia e Innovación, Spain
| | - P Gullón
- Universidad de Alcalá, Facultad de Medicina y Ciencias de La Salud, Departamento de Cirugía, Ciencias Médicas y Sociales, Grupo de Investigación en Epidemiología y Salud Pública, Alcalá de Henares, Madrid, Spain; Centre for Urban Research, RMIT University, Melbourne, Australia.
| | - U Bilal
- Universidad de Alcalá, Facultad de Medicina y Ciencias de La Salud, Departamento de Cirugía, Ciencias Médicas y Sociales, Grupo de Investigación en Epidemiología y Salud Pública, Alcalá de Henares, Madrid, Spain; Urban Health Collaborative, Drexel Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA; Department of Epidemiology and Biostatistics, Drexel Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA
| | - M Franco
- Universidad de Alcalá, Facultad de Medicina y Ciencias de La Salud, Departamento de Cirugía, Ciencias Médicas y Sociales, Grupo de Investigación en Epidemiología y Salud Pública, Alcalá de Henares, Madrid, Spain; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2217, USA
| |
Collapse
|
11
|
Garcia-Olive I, Lopez Seguí F, Hernandez Guillamet G, Vidal-Alaball J, Abad J, Rosell A. Impact of the COVID-19 pandemic on diagnosis of respiratory diseases in the Northern Metropolitan Area in Barcelona (Spain). Med Clin (Barc) 2023; 160:392-396. [PMID: 36822982 PMCID: PMC9868362 DOI: 10.1016/j.medcli.2022.11.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2022] [Revised: 11/10/2022] [Accepted: 11/11/2022] [Indexed: 01/24/2023]
Abstract
OBJECTIVE The COVID-19 pandemic has had a great effect on the management of chronic diseases, by limiting the access to primary care and to diagnostic procedures, causing a decline in the incidence of most diseases. Our aim was to analyze the impact of the pandemic on primary care new diagnoses of respiratory diseases. METHODS Observational retrospective study performed to describe the effect of COVID-19 pandemic on the incidence of respiratory diseases according to primary care codification. Incidence rate ratio between pre-pandemic and pandemic period was calculated. RESULTS We found a decrease in the incidence of respiratory conditions (IRR 0.65) during the pandemic period. When we compared the different groups of diseases according to ICD-10, we found a significant decrease in the number of new cases during the pandemic period, except in the case of pulmonary tuberculosis, abscesses or necrosis of the lungs and other respiratory complications (J95). Instead, we found increases in flu and pneumonia (IRR 2.17) and respiratory interstitial diseases (IRR 1.41). CONCLUSION There has been a decrease in new diagnosis of most respiratory diseases during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Ignasi Garcia-Olive
- Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
| | - Francesc Lopez Seguí
- Directorate for Innovation and Interdisciplinary Cooperation, North Metropolitan Territorial Authority, Catalan Institute of Health, Badalona, Barcelona, Spain,Center for Research in Economy and Health, Pompeu Fabra University, Barcelona, Spain
| | - Guillem Hernandez Guillamet
- Directorate for Innovation and Interdisciplinary Cooperation, North Metropolitan Territorial Authority, Catalan Institute of Health, Badalona, Barcelona, Spain,Center for Research in Economy and Health, Pompeu Fabra University, Barcelona, Spain
| | - Josep Vidal-Alaball
- Health Promotion in Rural Areas Research Group, Gerencia Territorial de la Catalunya Central, Institut Català de la Salut, Sant Fruitós de Bages, Barcelona, Spain,Unitat de Suport a la Recerca de la Catalunya Central, Fundacio Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina, Sant Fruitós de Bages, Barcelona, Spain,Faculty of Medicine, University of Vic – Central University of Catalonia, Vic, Barcelona, Spain
| | - Jorge Abad
- Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain,Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain,Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Antoni Rosell
- Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain,Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain,Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| |
Collapse
|
12
|
Mora N, Fina F, Méndez-Boo L, Cantenys R, Benítez M, Moreno N, Balló E, Hermosilla E, Fàbregas M, Guiriguet C, Cos X, Rodoreda S, Mas A, Lejardi Y, Coma E, Medina M. "Decline and uneven recovery from 7 common long-term conditions managed in the Catalan primary care after two pandemic years: an observational retrospective population-based study using primary care electronic health records". BMC PRIMARY CARE 2023; 24:9. [PMID: 36641483 PMCID: PMC9840158 DOI: 10.1186/s12875-022-01935-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Accepted: 12/01/2022] [Indexed: 01/15/2023]
Abstract
BACKGROUND The incidence of chronic diseases during the COVID-19 pandemic has drastically been reduced worldwide due to disruptions in healthcare systems. The aim of our study is to analyse the trends in the incidence of 7 commonly managed primary care chronic diseases during the last 2 years of the COVID-19 pandemic in Catalonia. METHODS We performed an observational retrospective population-based study using data from primary care electronic health records from January 2018 to August 2022 (5.1 million people older than 14 years). We divided the study period into two: a pre-pandemic period (before 14 March 2020) and a pandemic period. We performed a segmented regression analysis of daily incidence rates per 100,000 inhabitants of 7 chronic diseases: type 2 diabetes mellitus (T2DM), asthma, chronic obstructive pulmonary disease (COPD), ischemic heart disease (IHD), heart failure (HF), hypertension and hypercholesterolemia. In addition, we compared annual incidence between pandemic years (2020, 2021 and 2022) and 2019. Associated incidence rate ratios (IRR) were also calculated. Finally, we estimated the number of expected diagnoses during the pandemic period using data from 2019 and we compared it with the observed data. RESULTS We analysed 740,820 new chronic diseases' diagnoses. Daily incidence rates of all 7 chronic diseases were drastically interrupted on 14 March 2020, and a general upward trend was observed during the following months. Reductions in 2020 were around 30% for all conditions except COPD which had greater reductions (IRR: 0.58 [95% CI: 0.57 to 0.6]) and HF with lesser drops (IRR: 0.86 [95% CI: 0.84 to 0.88]). Some of the chronic conditions have returned to pre-pandemic diagnosis levels, except asthma, COPD and IHD. The return to pre-pandemic diagnosis levels compensated for the drops in 2020 for T2DM and HF, but not for hypertension which presented an incomplete recovery. We also observed an excess of hypercholesterolemia diagnoses of 8.5% (95%CI: 1.81% to 16.15%). CONCLUSIONS Although primary care has recovered the pre-pandemic diagnosis levels for some chronic diseases, there are still missing diagnoses of asthma, COPD and IHD that should be addressed.
Collapse
Affiliation(s)
- Núria Mora
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Francesc Fina
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Leonardo Méndez-Boo
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Roser Cantenys
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Mència Benítez
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain ,grid.22061.370000 0000 9127 6969Equip d’Atenció Primària de Gòtic, Institut Català de la Salut (ICS), Barcelona, Spain
| | - Nemesio Moreno
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Elisabet Balló
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Eduardo Hermosilla
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain ,grid.452479.9Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAPJGol), Barcelona, Spain
| | - Mireia Fàbregas
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Carolina Guiriguet
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain ,grid.22061.370000 0000 9127 6969Equip d’Atenció Primària de Gòtic, Institut Català de la Salut (ICS), Barcelona, Spain ,grid.5841.80000 0004 1937 0247Universitat de Barcelona, Barcelona, Spain
| | - Xavier Cos
- grid.22061.370000 0000 9127 6969Direcció Assistencial d’Atenció Primària i a la Comunitat, Institut Català de la Salut (ICS), Barcelona, Spain ,grid.22061.370000 0000 9127 6969DAP_Cat Research Group, Gerència Territorial Barcelona Ciutat, Institut Català de la Salut, Barcelona, Spain ,grid.7080.f0000 0001 2296 0625Universitat Autònoma de Barcelona, Barcelona, Spain ,grid.413448.e0000 0000 9314 1427CIBERDEM, ISCIII , Madrid, Spain
| | - Sara Rodoreda
- grid.22061.370000 0000 9127 6969Direcció Assistencial d’Atenció Primària i a la Comunitat, Institut Català de la Salut (ICS), Barcelona, Spain
| | - Ariadna Mas
- grid.22061.370000 0000 9127 6969Direcció Assistencial d’Atenció Primària i a la Comunitat, Institut Català de la Salut (ICS), Barcelona, Spain
| | - Yolanda Lejardi
- grid.22061.370000 0000 9127 6969Direcció Assistencial d’Atenció Primària i a la Comunitat, Institut Català de la Salut (ICS), Barcelona, Spain
| | - Ermengol Coma
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| | - Manuel Medina
- grid.22061.370000 0000 9127 6969Primary Care Services Information Systems (SISAP), Institut Català de la Salut (ICS), Gran Via de Les Corts Catalanes, 587, 08007 Barcelona, Spain
| |
Collapse
|
13
|
Guisado-Clavero M, Astier-Peña MP, Gómez-Bravo R, Ares-Blanco S. [Open data for monitoring COVID-19 in Spain: descriptive study]. Enferm Infecc Microbiol Clin 2022; 42:S0213-005X(22)00191-4. [PMID: 36249470 PMCID: PMC9554340 DOI: 10.1016/j.eimc.2022.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2022] [Accepted: 10/03/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND The indicators of the pandemic have been based on the total number of diagnosed cases of COVID-19, the number of people hospitalized or in intensive care units, and deaths from the infection. The aim of this study is to describe the available data on diagnostic tests, health service used for the diagnosis of COVID-19, case detection and monitoring. METHOD Descriptive study with review of official data available on the websites of the Spanish health councils corresponding to 17 Autonomous Communities, 2 Autonomous cities and the Ministry of Health. The variables collected refer to contact tracing, technics for diagnosis, use of health services and follow-up. RESULTS all regions of Spain show data on diagnosed cases of COVID-19 and deaths. Hospitalized cases and intensive care admissions are shown in all regions except the Balearic Islands. Diagnostic tests for COVID-19 have been registered in all regions except Madrid region and Extremadura, with scarcely information on what type of test has been performed (present in 7 CCAA), requesting service and study of contacts. CONCLUSIONS The information available on the official websites of the Health Departments of the different regions of Spain are heterogeneous. Data from the use of health service or workload in Primary Care, Emergency department or Out of hours services are almost non-existent.
Collapse
Affiliation(s)
- Marina Guisado-Clavero
- Técnica de Salud de la Unidad Docente Multiprofesional de Atención Familiar y Comunitaria del área norte de la Comunidad de Madrid, España
| | - María Pilar Astier-Peña
- Médica de familia. Centro de Salud Universitas del Servicio Aragonés de Salud (Zaragoza, España). GdT de Seguridad del paciente de semFYC y del GdT de Calidad y Seguridad de WONCA, Zaragoza, España
| | - Raquel Gómez-Bravo
- Research Group Self-Regulation and Health. Institute for Health and Behaviour. Department of Behavioural and Cognitive, Sciences. Faculty of Humanities, Education, and Social Sciences, Universidad de Luxemburgo, Luxemburgo
| | - Sara Ares-Blanco
- Médica de familia. Centro de Salud Federica Montseny, Gerencia Asistencial de Atención Primaria, Servicio Madrileño de Salud, Madrid, España. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| |
Collapse
|
14
|
Gullón P, Lumbreras B, Sánchez-Martínez FI, Jaaskelainen FDM, Ruiz-Cantero MT. La Salud Pública y la Administración Sanitaria ante la pandemia de COVID-19. Informe SESPAS 2022. GACETA SANITARIA 2022; 36 Suppl 1:S1-S3. [PMID: 35781140 PMCID: PMC9127046 DOI: 10.1016/j.gaceta.2022.05.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Accepted: 05/15/2022] [Indexed: 11/22/2022]
|